Steven K. Libutti, MD
Steven K. Libutti, MD, FACS was appointed Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences in January 2017. In addition to his leadership roles within Rutgers University, Dr. Libutti serves as Senior Vice President of Oncology Services for RWJBarnabas Health. He is also a Professor of Surgery at Rutgers Robert Wood Johnson Medical School and an Affiliated Distinguished Professor in Genetics, Rutgers School of Arts and Sciences. After graduating magna cum laude from Harvard College, Dr. Libutti received his medical degree from the College of Physicians and Surgeons of Columbia University. He remained at Presbyterian Hospital in New York where he completed his residency in surgery, followed by a fellowship at the National Cancer Institute (NCI) in surgical oncology and endocrine surgery. He continued at the NCI where he became a tenured Senior Investigator and Chief of the Tumor Angiogenesis Section in the Surgery Branch. Dr. Libutti is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors and Past President of the American Association of Endocrine Surgeons. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas. The recipient of funding from the NCI for the past 20 years, Dr. Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment as well as on a better understanding of the tumor suppressor genes MEN1 and FILIP1L. He has published over 300 peer reviewed journal articles, is Editor-in-Chief Emeritus of the Springer-Nature Journal Cancer Gene Therapy and holds eleven U.S. patents.Anita Kinney, PhD, RN
Dr. Anita Kinney has been an actively funded investigator in the area of cancer prevention and control for over 25 years with a focus on behavioral, ethical, social, and care delivery genetics research. Her research brings a combination of behavioral science, clinical, and epidemiologic perspectives to address unsolved cancer prevention and control problems in diverse populations and settings. Her overarching research goal is to understand variation in cancer risk, determinants of risk and outcomes, and to use this information to develop effective interventions that facilitate informed decision-making, positive changes in health behaviors, and guideline-concordant genomic care delivery that leads to better outcomes. Much of Dr. Kinney’s research has focused on documenting determinants of interest, access and use of genomic tests, and related health services in diverse populations, and using this information to better understand and address health disparities. She has also had considerable experience in community engagement, leading and collaborating on large community-based and population-based randomized trials that have developed and implemented effective interventions to promote cancer risk assessment and screening in average-risk and high-risk populations, and appropriate translation of genetic discoveries into clinical practice. Further, Dr. Kinney has pioneered effective culturally targeted and telehealth genetic risk communications, behavior change (including cancer screening), and gene testing interventions in cancer survivors and their relatives. In addition, she has produced over 140 peer-reviewed publications, mentored and trained over 50 students, postdocs and junior faculty, and successfully built cancer population science and community outreach infrastructure at Rutgers and other cancer centers.
Celette Sugg Skinner, Ph.D.
Celette Sugg Skinner, Ph.D., is Professor and Inaugural Chair of the Department of Population & Data Sciences at the University of Texas Southwestern Medical Center. A pioneer in computer-tailored communications, Dr. Skinner has spent 30 years developing and testing innovative behavior-change interventions, working primarily among traditionally underserved groups. Her recent work focuses on multilevel interventions that meaningfully use electronic health records to identify patients in need of intervention, use clinically collected information to generate and deliver algorithm-driven tailored interventions, and track intervention outcomes. Dr. Skinner, who holds the Parkland Community Medicine Professorship, is a member of the Harold C. Simmons Comprehensive Cancer Center. Since 1994, when she was a member of the National Cancer Institute’s (NCI) first Working Group on Computerized Tailored Interventions, she has been a frequently invited participant in NCI “think tanks” to address cancer prevention and disparities. In 2016, she was the only UT Southwestern faculty member to serve on the Beau Biden Cancer Moonshot Blue Ribbon Panel, working with a group to set national priorities for dissemination and implementation research. Dr. Skinner joined UT Southwestern in 2007 as Chief of the Division of Behavioral and Communication Sciences and as the founding Associate Director of Population Research for the Simmons Cancer Center. She previously served as Associate Director for Population Research for the Duke Cancer Institute. Before that, she was a member of the Siteman Cancer Center of Washington University in St. Louis (1993-1998) and the Indiana University Simon Cancer Center (1991-1993). Dr. Skinner received an M.A. in Communications Research from The Wheaton Graduate School and a Ph.D. in Health Behavior from the University of North Carolina at Chapel Hill, where she serves as an Adjunct Professor in the Gillings School of Global Public Health and Chairs the Public Health Foundation Board.
Michael Steinberg, MD, MPH
Dr. Michael Steinberg is Professor and Chief in the Division of General Internal Medicine, Vice-Chair for Research at the Rutgers Robert Wood Johnson Medical School, and Medical Director of the Rutgers Tobacco Dependence Program/Center for Tobacco Studies. Dr. Steinberg has served as a Fellow of the American College of Physicians since 2010, is a former RWJ Foundation Physician Faculty Scholar (2006-9), and is a past-president of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). He maintains an active research career in the areas of tobacco treatment interventions, has published over 75 peer-reviewed manuscripts, and has conducted studies funded by NCI, NIDA, RWJ Foundation, and the NJ Department of Health. His ongoing efforts include an NCI-funded R01 study evaluating physicians’ attitudes and communication regarding E-cigarettes (PACE), coordination and training for the 10 New Jersey tobacco Quitcenters, and assisting with the SCREEN NJ Lung Screening initiative.Heather Jordan, MPH, CPH, MCHES
Ms. Jordan is currently a Research Program Manager at the Robert Wood Johnson Medical School and the Center for Tobacco Studies at Rutgers, The State University of New Jersey. She currently coordinates the Tobacco Free Healthy New Jersey Quit Centers and healthcare provider lung cancer screening education for ScreenNJ. Ms. Jordan has over 20 years of progressive work experience in program planning, administration, and evaluation; finance, operations management, and human resources management; and other research related endeavors in the academic, for-profit public health consultative, and non-profit sectors. Ms. Jordan is also a part-time PhD student in the Department of Health Behavior, Society, & Policy at the Rutgers School of Public Health. She holds a Master’s Degree in Public Health with a concentration in Maternal and Child Health from The George Washington University, and a Bachelor’s degree with dual concentrations in Marketing and Health Planning/Management from Alfred University. She is Certified in Public Health (CPH) and a Master Health Education Specialist (MCHES). She has completed the Rutgers Sponsored Programs Academy for Continuing Education (S.P.A.C.E.) Certificate Program and the Rutgers Tobacco Dependence Program 4-Day Tobacco Treatment Specialist training program.